Black phosphorus (BP) is a novel plasmonic materials at the infrared and terahertz regions. We have theoretically investigated the anisotropic of in-plane monolayer BP in terms of conductivity. We have designed a periodic structure for a special shape and achieved an obvious plasmon-induced transparency phenomenon. The results of finite difference time domain simulation and coupled mode theory are in consistent good agreement. It is found that the bandwidth of plasmon-induced transparency phenomenon window can be effectively adjusted by changing the shape of the BP structure. Since the structure of the monolayer BP is completely continuous, it is easy to change the carrier density to adjust its resonance intensity and resonance frequency, which basically ensures the tunability of the plasmon-induced transparency phenomenon. This structure has an excellent slow light effect, and the maximum group index of this structure is 112. This research may open new doors for the application of monolayer BP in transmission modulation, especially for the modulation of slow light device.
A novel monolayer graphene structure whose unit cell possesses two rectangular defects is proposed. A very obvious dual plasmon-induced transparency (PIT) effect can be successfully achieved by the destructive interference in the terahertz region. The dual PIT effect can be easily tuned by changing the Fermi energy of the monolayer graphene. Since the graphene of our structure exists in a continuous form, we can simply apply a bias voltage to achieve the tuning performance compared to those structures with discontinuous graphene patterns. We have deduced the expression of the theoretical transmittance and the numerical simulation results are very consistent with the theoretical data. Moreover, we find that this structure has a good slow light property and its group refractive index is as high as 545. Thus, the proposed structure and findings may provide a good guidance for the highly tunable optoelectronic devices and excellent slow light device.
Cardiovascular disease (CVD) is still the leading cause of death globally, and atherosclerosis is the main pathological basis of CVDs. Low-density lipoprotein cholesterol (LDL-C) is a strong causal factor of atherosclerosis. However, the first-line lipid-lowering drugs, statins, only reduce approximately 30% of the CVD risk. Of note, atherosclerotic CVD (ASCVD) cannot be eliminated in a great number of patients even their LDL-C levels meet the recommended clinical goals. Previously, whether the elevated plasma level of triglyceride is causally associated with ASCVD has been controversial. Recent genetic and epidemiological studies have demonstrated that triglyceride and triglyceride-rich lipoprotein (TGRL) are the main causal risk factors of the residual ASCVD. TGRLs and their metabolites can promote atherosclerosis via modulating inflammation, oxidative stress, and formation of foam cells. In this article, we will make a short review of TG and TGRL metabolism, display evidence of association between TG and ASCVD, summarize the atherogenic factors of TGRLs and their metabolites, and discuss the current findings and advances in TG-lowering therapies. This review provides information useful for the researchers in the field of CVD as well as for pharmacologists and clinicians.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.